In multiple sclerosis (MS) patients, low levels of IL-10 mRNA in peripheral blood monocytes (PBMC) are associated with relapse and with secondary progressive disease (Van Boxel-Dezaire et al., 1999). Here, IL10 is linked to myeloid sarcoma.